0114-9954
Reactions Weekly
Adis, Springer Healthcare · New Zealand
- APC
- —
- Time to publish
- —
- Articles/yr
- 298,762
Open access
DOAJ
No APC
Active
中国肺癌杂志
Zhongguo feiai zazhi/Zhongguo fei'ai zazhi · Chinese Journal of Lung Cancer · Zhongguo Fei’Ai Zazhi
ISSN:1009-3419, 1999-6187
Chinese Anti-Cancer Association; Chinese Antituberculosis Association · China · 2000
Submission → publication14 weeks
APCNo APC
DOAJ✓
Earliest year2000
Value profile v0.1
Topics
Lung Cancer Diagnosis and Treatment33%
Lung Cancer Treatments and Mutations14%
Lung Cancer Research Studies9%
Cancer Immunotherapy and Biomarkers4%
Brain Metastases and Treatment4%
Myasthenia Gravis and Thymoma4%
Prostate Cancer Treatment and Research2%
S100 Proteins and Annexins2%
Academic impact
- Cited at least once
- 9%
- Top 10% share of citations
- 100%
- Median citations
- 0
Originality (citation structure)
—
Integrity
Retracted: 0
Most cited works
- Androgen Receptor Is a Tumor Suppressor and Proliferator in Prostate Cancer 2009 · 3 cites
- Targeting Annexin A7 in Hepatocarcinoma Lymphatic Metastasis 2009 · 3 cites
- Anti-metastatic Effect of Repeated Cyclic- GRGDSPA Peptide Produced by Intein Protein Trans-splicing on Murine B16 Melanoma Cells 2009 · 2 cites
- The Predictive Values of Expression Level of WIF-1, Gsk-3B and Nm23-H1 in the Patients with Non-Small Cell Lung Cancer 2009 · 1 cites
- Alterations and Its Mechanisms of Wnt Signal Pathway in Human High-matastatatic Large Cell Lung Cancer Cell Line L9981 by Transfecting with Nm23-H1 Gene 2009 · 1 cites
Most recent works
- PD-1/PD-L1抑制剂在非小细胞肺癌中的临床研究进展 2019 · 0 cites
- 非小細胞肺癌における予後バイオマーカーとしての腫瘍随伴白血球増加症と血小板増加症【Powered by NICT】 2016 · 0 cites
- Androgen Receptor Is a Tumor Suppressor and Proliferator in Prostate Cancer 2009 · 3 cites
- Targeting Annexin A7 in Hepatocarcinoma Lymphatic Metastasis 2009 · 3 cites
- Anti-metastatic Effect of Repeated Cyclic- GRGDSPA Peptide Produced by Intein Protein Trans-splicing on Murine B16 Melanoma Cells 2009 · 2 cites
Based on 55 works from OpenAlex (CC0) · method v0.1
Basic information
- Publisher
- Chinese Anti-Cancer Association; Chinese Antituberculosis Association
- Country/Region
- China
- Subject
- Medicine
- Open access
- ✓ (gold)
- DOAJ
- ✓
- License
- CC BY
- Earliest year
- 2000
- DOAJ article records
- 2,718
- Journal website
- https://www.med126.com
- Verify this journal
- Master Journal List ↗ · DOAJ ↗
- Submission page
- http://www.lungca.org/files/instructions-EN.pdf
Reference data How to read journal metrics →
Articles/yr291
h-index2
2-yr mean citedness0.00
Last publication year2020
DOAJ article records2,718
Open access✓
“2-yr mean citedness” is the OpenAlex field summary_stats.2yr_mean_citedness (CC0): mean citations per paper over a two-year window. It is a raw bibliometric field, not a journal rating, and is not used for default ranking.
Correct a record · Request removal
Subject classification
Medicine144
Biochemistry, Genetics and Molecular Biology44
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens1
§
More →
Journals in the same subject
0006-4971
Blood
Elsevier BV · United States
- APC
- $5,500
- Time to publish
- —
- Articles/yr
- 183,281
0732-183X
Journal of Clinical Oncology
Lippincott Williams & Wilkins · United States
- APC
- —
- Time to publish
- —
- Articles/yr
- 170,452
0016-5085
Gastroenterology
Elsevier BV · United States
- APC
- $4,180
- Time to publish
- —
- Articles/yr
- 154,907
0022-5347
The Journal of Urology
Lippincott Williams & Wilkins · United States
- APC
- $3,000
- Time to publish
- —
- Articles/yr
- 147,097
0892-6638
The FASEB Journal
Wiley · United States
- APC
- $3,740
- Time to publish
- —
- Articles/yr
- 139,152